Literature DB >> 2947159

[Cardiotoxicity of 5-fluorouracil. Characteristics, mechanism, practical management].

B Escudier, J B Alexandre, B Leclercq, P Morin, J M Guyot, G Nitenberg.   

Abstract

5-fluorouracil is a drug that is widely used in cancerology. Its cardiotoxicity must be known, as it is not exceptional and potentially dangerous. Two cases are reported in which the coronary insufficiency was documented and recurred when 5-fluorouracil was reintroduced. The mechanism of cardiac toxicity seems to be coronary spasm, as shown by exercise tests and the normal results of coronary arteriography. It seems preferable to refrain from using 5-fluorouracil after a recent myocardial infarction or in patients with unstable angina. Reintroduction of the drug is usually followed by recurrence of cardiotoxicity, even under coronary vasodilators.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947159

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  The clinical syndrome of 5-fluorouracil cardiotoxicity.

Authors:  J F Ensley; B Patel; R Kloner; J A Kish; J Wynne; M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 2.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  Acute myocardiotoxicity during 5-fluorouracil therapy.

Authors:  B Misset; B Escudier; B Leclercq; D Rivara; P Rougier; G Nitenberg
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.